The IPO calendar has been packed this year, with 40 companies going public year to date. And this week we see another four companies make their public debuts.
The healthcare field once again leads the way with three of this week's IPOs. In 2014, 22 healthcare companies have gone public.
Investors looking to play the IPO market have some interesting options this week as these companies all hit the market...
March 2014 IPO Calendar: Four IPOs to Watch
Achaogen Inc. (Nasdaq: AKAO) will make its public debut on Wednesday, March 12, on the Nasdaq. AKAO is a clinical-stage biopharmaceutical company that develops drugs to fight multidrug-resistant infections. The company's lead product, plazomicin, is currently in phase 3 trials and is designed to fight serious bacterial infections.
AKAO reported a net loss for the first nine months of 2013, but could start seeing huge profits if plazomicin is successful.
Investing in IPOs like Achaogen, or other pharmaceuticals, has the potential for huge payoffs, but it can also be risky...
Diamond S Shipping Group Inc. (DSG) is a shipper of refined petroleum and operates a fleet of 33 medium-range tankers. According to the research firm Fearnley Consultants AS, Diamond is one of the largest owners and operators of medium-range tankers in the world.
DSG will be offering 14 million shares at a price range of $14 to $16 per share through its IPO. By selling shares at the midpoint of that range, Diamond will raise approximately $210 million. The company plans to purchase 10 new tankers, which will be partially funded by its initial public offering.
In 2013, Diamond Shipping reported $178 million in revenue. The company will begin trading on the New York Stock Exchange on Wednesday, March 12. Bank of America Merrill Lynch and Jefferies LLC are the lead underwriters for DSG.
Note: The IPO market is back, and that means there are huge profit opportunities for investors. These eight IPOs should be on every investor's radar in 2014...
Another healthcare IPO week is Dipexium Pharmaceuticals LLC (Nasdaq: DPRX), which will go public on Thursday, March 13.
Dipexium is a late-stage pharmaceutical company that is currently developing Locilex, a topical antibiotic used to treat diabetic foot ulcers. DPRCX is the smallest IPO this week, as the company is looking to raise approximately $30 million by selling 2.3 million shares at a $12 to $14 range.
Oppenherimer and Co. Inc. is the lead underwriter on the IPO. The company was founded in 2010 and is headquartered in New York, NY.
The last company going public this week is Castlight Health Inc. (NYSE: CSLT), which will debut on Friday, March 14, on the New York Stock Exchange.
Castlight is a cloud-based healthcare software company that works primarily with self-insured employers. The company will be offering its shares at a range of $9 to $11 in its IPO. It is looking to raise approximately $111 million by selling 11.1 million shares. That would give the company a market cap of $1 billion.
Which IPOs this week look the best to you? Are you investing in any of them? Share your thoughts on Twitter @moneymorning using #IPOs.
We're seeing bullish developments that point to huge gains in the burgeoning uranium market. Here's how to play that surging bull market...